R-Etodolac decreases β-catenin levels along with survival and proliferation of hepatoma cells
- 31 May 2007
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 46 (5), 849-857
- https://doi.org/10.1016/j.jhep.2006.11.017
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Morpholino oligonucleotide-triggered β-catenin knockdown compromises normal liver regenerationJournal of Hepatology, 2005
- β-Catenin and Met Deregulation in Childhood HepatoblastomasPediatric and Developmental Pathology, 2005
- Targeting the beta‐catenin/APC pathway: a novel mechanism to explain the cyclooxygenase‐2‐independent anticarcinogenic effects of celecoxib in human colon carcinoma cellsThe FASEB Journal, 2005
- Prostaglandin E 2 promotes migration and adhesion in hepatocellular carcinoma cellsCarcinogenesis: Integrative Cancer Research, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionThe New England Journal of Medicine, 2005
- β-catenin-mediated signaling: a molecular target for early chemopreventive interventionMutation research. Reviews in mutation research, 2004
- Regulating the Balance between Peroxisome Proliferator-activated Receptor γ and β-Catenin Signaling during AdipogenesisOnline Journal of Public Health Informatics, 2004
- Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARγCancer Cell, 2004
- Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cellsHepatology, 2002
- The spatially one-dimensional relativistic Ornstein-Uhlenbeck process in an arbitrary inertial frameZeitschrift für Physik B Condensed Matter, 2001